Weekly Paclitaxel plus Capecitabine versus Docetaxel Every 3 Weeks plus Capecitabine in Metastatic Breast Cancer

<table>Kaplan/Meier analysis of time to treatment failure. Whole line: Weetax. Dotted line: Threetax. Median time to treatment failure: Weetax: 174 days. Threetax: 147 days (<svg height="10.9125" id="M52" style="vertical-align:-0.17555pt" version="1.1" viewbox="0 0 63.962502 10.9125" width="63.962502" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,10.9125)">
<g transform="translate(72,-63.27)">
<text transform="matrix(1,0,0,-1,-71.95,63.5)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑃</tspan>
<tspan style="font-size: 12.50px; " x="10.890113" y="0">=</tspan>
<tspan style="font-size: 12.50px; " x="22.930502" y="0">0</tspan>
<tspan style="font-size: 12.50px; " x="29.182001" y="0">.</tspan>
<tspan style="font-size: 12.50px; " x="32.307751" y="0">4</tspan>
<tspan style="font-size: 12.50px; " x="38.559254" y="0">7</tspan>
<tspan style="font-size: 12.50px; " x="44.810753" y="0">2</tspan>
</text>
</g>
</g>
</svg>, n.s).</table>

Journal of Oncology

fig1

Figure 1

Figure 1: Weekly Paclitaxel plus Capecitabine versus Docetaxel Every 3 Weeks plus Capecitabine in Metastatic Breast Cancer 